
Friday, March 03, 2017 10:33:16 AM
Growblox Sciences, Inc. (Growblox) is engaged in developing and utilizing technologies in plant biology, cultivation and extraction techniques combined with biotechnology, and plans to produce medical-grade cannabis, cannabis concentrates and cannabinoid therapies. The Company seeks to be a technology and solution company that converts the cannabis plant into medicines, therapies and treatments for a range of ailments. Growblox intends to conduct its business operations, through its subsidiaries, in approximately three operating units, which include Solutions, Sciences and Product divisions.
GB Solutions
The Solutions division involves the development and use of its suite of controlled-climate indoor agricultural technology growing and cultivation Suites, including TissueBLOX, GrowBLOX, CureBLOX and ExtractionLAB.
GB Sciences
GB Sciences’ Drug Development program endeavors to provide novel cannabinoid therapies to patients with critically unmet needs. Starting with certified, cannabis plant-derived ingredients from the GrowBLOX™ technology suite, GB Sciences tests proprietary ratios of active ingredients in an accelerated drug development program.
GB Products
The GBLX line of products is the signature collection of cannabinoid therapies developed and produced by GrowBlox Sciences. Infused with certified-active ingredients derived from cannabis plants grown using the GrowBLOX system. This line of product features proprietary cannabinoid and terpenoid blends that are being extensively studied for optimal efficacy.
GB Sciences Unique Retail Solution – The Apothecary
GB Sciences has designed a unique retail environment for cannabinoid therapy providers to deliver exceptional patient care. The Apothecary by GB Sciences combines a simple, clean and clinical design with cutting edge bio-metrics and patient verification to deliver a pleasant and safe customer experience.Highly trained and certified ApotheCAREians will work with patients to determine their medical needs, identify therapeutic products, install GB Sciences’ app on their hand-held devices, and demonstrate how to place orders.
The Micro Apothecary is a self-service vending kiosk. The interactive LED monitors display essential product and patient safety information and doubles as the touch screen interface that allows you to create a new patient profile or sign in to an existing account.
The Apothecary will have a mobile app as a powerful tool for building a strong patient- dispensary relationship.
Check out these videos outlining the features of “The Apothecary” and the proposed mobile app and read more about GBLX’s retail solutions at http://growblox.com/gbs-production/distrubution.html
In My Own Personal Opinion Of Course!

Liked By
Spread the love. Be the first to like this post!
Recent GBLX News
- Quarterly Report (10-q) • Edgar (US Regulatory) • 02/03/2023 08:30:25 PM
- Additional Proxy Soliciting Materials (definitive) (defa14a) • Edgar (US Regulatory) • 01/23/2023 07:09:50 PM
- Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a) • Edgar (US Regulatory) • 12/14/2022 07:53:52 PM
- Prospectus Filed Pursuant to Rule 424(b)(3) (424b3) • Edgar (US Regulatory) • 11/10/2022 09:35:10 PM
- Quarterly Report (10-q) • Edgar (US Regulatory) • 11/09/2022 05:22:42 PM
- Annual Report (10-k) • Edgar (US Regulatory) • 06/30/2022 08:03:25 PM
- Small Company Offering and Sale of Securities Without Registration (d) • Edgar (US Regulatory) • 06/03/2022 06:08:45 PM
- Current Report Filing (8-k) • Edgar (US Regulatory) • 03/16/2022 06:36:31 PM
- Prospectus Filed Pursuant to Rule 424(b)(3) (424b3) • Edgar (US Regulatory) • 03/10/2022 09:37:50 PM
TNRG Signs Reg A Offering Agreement • TNRG • Feb 3, 2023 10:30 AM
Trend Innovations Holding Inc. Thy News Application Review Year 2022 and Update Toward 2023 • TREN • Feb 2, 2023 2:00 PM
Goldshore Intersects 9.46 g/t Au over 7.45m in the Southwest Zone Widths of Mineralized System Expanded Significantly. • GSHRF • Feb 2, 2023 9:58 AM
Hempacco and Snoop Dogg Create Joint Venture to Launch Consumer Goods Powerhouse of Hemp and Hemp-Derived Products • HPCO • Feb 2, 2023 9:30 AM
Kona Gold Beverage, Inc Announces Record Revenue Month in January Eclipsing Half a Million Dollars for the First Time • KGKG • Feb 2, 2023 9:00 AM
BioLife Sciences Inc. (OTC: BLFE) Announces Letter of Intent for Exclusive Licensing Deal with Canadian Firm • BLFE • Feb 2, 2023 8:32 AM